Neurovascular Devices Market: Comprehensive Analysis and
Strategic Insights
The Neurovascular Devices market is experiencing robust
growth driven by the increasing prevalence of neurovascular diseases,
advancements in medical technology, and a growing aging population.
Neurovascular devices are critical in the treatment of conditions such as
aneurysms, stenosis, ischemic strokes, and arteriovenous malformations. This
report provides a detailed analysis of the Neurovascular Devices market,
including market dynamics, segmentation, key trends, and strategic insights,
aimed at offering stakeholders valuable information to navigate the evolving
market landscape effectively.
Neurovascular intervention, a field often referred to as
vascular neurosurgery or interventional radiology, involves non-surgical,
minimally invasive treatments for neurovascular diseases under imaging
guidance. Utilizing tools like x-ray fluoroscopy, this approach enables precise
interventions for various conditions affecting the brain and spinal cord.
Key Techniques and
Tools in Neurovascular Intervention
Endovascular
Approach
Most neurovascular interventions are performed using a
percutaneous approach, with the common femoral artery being the preferred
route. Occasionally, the radial artery or other accessible vessels are used.
The goal is to reach the target lesion with minimal invasion, allowing for
treatments like embolization, angioplasty, and stenting.
Guiding
Catheters
A fundamental tool in neurovascular procedures, guiding
catheters provide a stable pathway from the puncture site to the lesion. These
catheters vary in size and flexibility, with some equipped with balloons for
flow control. The choice of catheter depends on the specific procedure and
device compatibility.
Microcatheters and
Guide Wires
Microcatheters, essential for navigating the intricate
pathways of the brain's vasculature, are designed to be longer and more
flexible. Paired with micro guide wires, they allow precise delivery of
therapeutic devices to the target site. These tools are crucial for procedures
like coil embolization and thrombectomy.
Common Neurovascular
Interventions
Aneurysm
Treatment
Cerebral aneurysms, which can lead to life-threatening
hemorrhages if ruptured, are commonly treated with coil embolization. This
technique involves placing coils within the aneurysm to promote clotting and
prevent rupture. Flow diverters, a newer approach, use fine mesh stents to
redirect blood flow away from the aneurysm, encouraging natural healing and
occlusion.
Arteriovenous
Malformations (AVMs) and Fistulas
AVMs, abnormal connections between arteries and veins, can
cause significant neurological issues. Treatments include embolization,
surgical excision, and radiosurgery, often used in combination. Embolization
involves injecting materials to block abnormal vessels, reducing the risk of
hemorrhage and preparing the AVM for surgery or further treatment.
Acute Ischemic
Stroke
Prompt treatment of ischemic strokes, caused by clots
blocking blood flow to the brain, is critical. Techniques like mechanical
thrombectomy use stent retrievers or aspiration catheters to remove clots and
restore circulation. This approach significantly improves outcomes for stroke
patients by minimizing brain damage.
Stenosis
Treatment
Stenosis, or narrowing of blood vessels, can lead to reduced
blood flow and increased stroke risk. Balloon angioplasty, often followed by
stenting, is used to widen the affected vessels. Anti-embolic devices, such as
filters or balloon guiding catheters, are employed during these procedures to
capture debris and prevent distal embolism.
Emerging Innovations
The field of neurovascular intervention is continually
evolving with advancements in technology and devices. Innovations in embolic
materials, stents, and neurovascular devices are enhancing the efficacy and
safety of these procedures. For instance, flow diverters represent a
significant advancement in aneurysm treatment, offering a less invasive
alternative to traditional methods.
Embolization Devices
Embolic Coils: Embolic
coils are devices used to occlude blood vessels and are commonly used in the
treatment of aneurysms. These coils are made of materials like platinum, which
is both flexible and visible under x-ray imaging. When deployed into an
aneurysm, the coils promote blood clotting within the aneurysm sac, which helps
to prevent rupture. They can be delivered through microcatheters and come in
various shapes and sizes to fit the specific anatomical requirements of the
target vessel.
Flow Diverters: Flow
diverters are stent-like devices used primarily to treat wide-necked or
fusiform aneurysms that are difficult to manage with coils alone. These devices
are placed in the parent artery at the site of the aneurysm. They divert blood
flow away from the aneurysm by creating a scaffold across the neck of the
aneurysm, which reduces blood flow into the aneurysm and promotes clot
formation within it. This method helps to occlude the aneurysm while maintaining
blood flow through the parent vessel.
Liquid Embolics: Liquid
embolics are agents that solidify upon injection, used to occlude blood
vessels. Two main types are cyanoacrylate (glue) and Onyx (ethylene-vinyl
alcohol copolymer). Cyanoacrylate polymerizes rapidly on contact with blood,
forming a solid mass that blocks the vessel. Onyx, on the other hand, is a
non-adhesive agent that forms a solid mass gradually, allowing for more
controlled delivery and precise embolization. These materials are particularly
useful in treating arteriovenous malformations (AVMs) and other vascular
malformations.
Revascularization
Devices
Stent Retrievers: Stent
retrievers are used in mechanical thrombectomy procedures to remove clots from
arteries in patients with acute ischemic stroke. These devices are deployed
through a microcatheter to the site of the clot, where they expand and
integrate into the clot material. The device, along with the clot, is then
retrieved, restoring blood flow to the affected area. Stent retrievers have
significantly improved outcomes in stroke patients by providing rapid and
effective clot removal.
Suction Devices: Suction
devices, or aspiration catheters, are another method used in mechanical
thrombectomy. These devices are advanced to the site of the clot, and negative
pressure is applied to aspirate the clot material directly. Suction devices can
be used alone or in combination with stent retrievers to enhance clot removal
efficiency. They are particularly useful in cases where the clot is soft and
can be aspirated intact.
Thrombectomy Devices
Support Devices: Support
devices in thrombectomy procedures include guide catheters and intermediate
catheters that provide stability and support for the delivery of therapeutic
devices. These devices facilitate the safe navigation of the vascular system
and ensure precise positioning of thrombectomy tools.
Microcatheters: Microcatheters
are thin, flexible catheters used to navigate the complex and tortuous pathways
of the cerebrovascular system. They are essential for delivering embolic
materials, stent retrievers, and other therapeutic devices to the target site.
Microcatheters are designed to provide flexibility and control, allowing
interventionalists to reach difficult locations within the brain's vasculature.
Microguidewires: Microguidewires
are used in conjunction with microcatheters to navigate through the vascular
system to the site of the lesion. These guidewires are incredibly thin and
flexible, enabling them to traverse narrow and tortuous vessels. They provide
the necessary support and direction for microcatheters, ensuring accurate
delivery of therapeutic devices.
Market Overview
Neurovascular devices are used in the diagnosis and
treatment of various neurovascular disorders affecting the central nervous
system. These devices include catheters, embolic coils, stents, and clot
retrieval devices, among others. The increasing incidence of neurovascular
diseases, coupled with technological advancements in imaging and surgical
techniques, is driving the demand for neurovascular devices. Moreover, the
growing emphasis on minimally invasive procedures is further propelling market
growth.
Segmentation Analysis
1. By Product Type:
- Embolization
Devices
- Embolic Coils
- Flow Diverters
- Liquid Embolics
- Revascularization
Devices
- Stent
Retrievers
- Suction Devices
- Thrombectomy
Devices
- Support Devices
- Microcatheters
- Microguidewires
2. By Application:
- Cerebral
Aneurysms
- Ischemic Strokes
- Arteriovenous
Malformations (AVMs)
- Stenosis
3. By End-User:
- Hospitals
- Specialty Clinics
- Ambulatory
Surgical Centers
4. Disease Pathology:
- Cerebral Ameurysm
- Ischemic Stroke
- Carotid Artery
Stenosis
- Arteriovenous
Malformation and Fistulas
5. By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &
Africa
Dominating Companies
in Neurovascular Devices Market
- STRYKER
- MEDTRONIC
- Johnson & Johnson (Cerenovus)
- Neuravi Ltd. (acquired by Johnson & Johnson)
- TERUMO CORPORATION
- PENUMBRA, INC.
- MICROPORT SCIENTIFIC CORPORATION
- BALT
- KANEKA CORPORATION
- PHENOX GMBH
- ASAHI INTECC CO., LTD
- PERFLOW MEDICAL LTD.
- RAPID MEDICAL
- CERUS ENDOVASCULAR INC.
- ACANDIS GMBH
- EVASC
- SENSOME
- LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
- IMPERATIVE CARE
- MEDIKIT CO., LTD.
- ZYLOX-TONBRIDGE MEDICAL CO., LTD.
- SILK ROAD MEDICAL, INC.
- ARTIO MEDICAL, INC.
- IVASCULAR
- OXFORDENDOVASCULAR
- NEUROVASC TECHNOLOGIES, INC
- Abbott Laboratories
- Acandis GmbH & Co. KG
- InspireMD, Inc.
- Integra LifeSciences Holdings Corporation
- Merit Medical Systems, Inc.
- Vascular Solutions (a subsidiary of Teleflex Incorporated)
Key Insights
- Technological
Advancements: Continuous innovations in neurovascular devices, such as the
development of next-generation stent retrievers and flow diverters, are
enhancing the efficacy and safety of neurovascular interventions.
- Increasing
Incidence of Neurovascular Diseases: The rising prevalence of conditions
such as stroke, aneurysms, and AVMs is significantly driving the demand for
neurovascular devices.
- Minimally Invasive
Procedures: Growing preference for minimally invasive procedures due to
their benefits, including reduced hospital stays and quicker recovery times, is
boosting the adoption of neurovascular devices.
- Aging Population:
The global aging population, which is more susceptible to neurovascular
disorders, is a major factor contributing to market growth.
- Healthcare
Infrastructure: Improvements in healthcare infrastructure, particularly in
emerging economies, are facilitating better access to advanced neurovascular
treatments.
Market Drivers
1. Rising Prevalence
of Neurovascular Disorders: Increasing cases of neurovascular diseases such
as stroke and aneurysms are driving the need for effective diagnostic and
treatment devices.
2. Advancements in
Medical Technology: Innovations in imaging technologies and the development
of advanced neurovascular devices are improving treatment outcomes and driving
market growth.
3. Growing Demand for
Minimally Invasive Procedures: The benefits associated with minimally
invasive neurovascular procedures, including reduced risk and faster recovery,
are increasing their adoption.
4. Supportive
Government Policies: Favorable government initiatives and funding for
research and development in neurovascular treatments are supporting market
expansion.
5. Awareness and
Screening Programs: Increased awareness and screening for neurovascular
diseases are leading to early diagnosis and treatment, thereby boosting the
demand for neurovascular devices.
Conclusion
The Neurovascular Devices market is poised for significant
growth, driven by the increasing prevalence of neurovascular disorders,
technological advancements, and the growing aging population. Understanding
market segmentation, key drivers, and emerging trends is essential for
stakeholders to capitalize on opportunities and address challenges in the
neurovascular devices industry. As the market evolves, the focus will likely
intensify on the development of advanced, minimally invasive devices that improve
patient outcomes and reduce healthcare costs.
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.